vs

Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and BLACKBERRY Ltd (BB). Click either name above to swap in a different company.

ACADIA PHARMACEUTICALS INC is the larger business by last-quarter revenue ($268.1M vs $141.8M, roughly 1.9× BLACKBERRY Ltd). BLACKBERRY Ltd runs the higher net margin — 9.7% vs 1.4%, a 8.3% gap on every dollar of revenue. On growth, ACADIA PHARMACEUTICALS INC posted the faster year-over-year revenue change (9.7% vs -0.8%). Over the past eight quarters, BLACKBERRY Ltd's revenue compounded faster (17.8% CAGR vs 5.3%).

Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.

BlackBerry Limited, formerly Research In Motion (RIM), is a Canadian software company specializing in secure communications and the Internet of Things (IoT). Founded in 1984, it developed the BlackBerry brand of two-way pagers, smartphones, and tablets. The company later transitioned to providing software and services and holds critical software application patents.

ACAD vs BB — Head-to-Head

Bigger by revenue
ACAD
ACAD
1.9× larger
ACAD
$268.1M
$141.8M
BB
Growing faster (revenue YoY)
ACAD
ACAD
+10.6% gap
ACAD
9.7%
-0.8%
BB
Higher net margin
BB
BB
8.3% more per $
BB
9.7%
1.4%
ACAD
Faster 2-yr revenue CAGR
BB
BB
Annualised
BB
17.8%
5.3%
ACAD

Income Statement — Q1 FY2026 vs Q3 FY2026

Metric
ACAD
ACAD
BB
BB
Revenue
$268.1M
$141.8M
Net Profit
$3.6M
$13.7M
Gross Margin
77.5%
Operating Margin
-1.7%
8.4%
Net Margin
1.4%
9.7%
Revenue YoY
9.7%
-0.8%
Net Profit YoY
224.5%
EPS (diluted)
$0.02
$0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACAD
ACAD
BB
BB
Q1 26
$268.1M
Q4 25
$284.0M
$141.8M
Q3 25
$278.6M
$129.6M
Q2 25
$264.6M
$121.7M
Q1 25
$244.3M
$141.7M
Q4 24
$259.6M
$143.6M
Q3 24
$250.4M
$126.2M
Q2 24
$242.0M
$123.4M
Net Profit
ACAD
ACAD
BB
BB
Q1 26
$3.6M
Q4 25
$273.6M
$13.7M
Q3 25
$71.8M
$13.3M
Q2 25
$26.7M
$1.9M
Q1 25
$19.0M
$-7.4M
Q4 24
$143.7M
$-10.5M
Q3 24
$32.8M
$-19.7M
Q2 24
$33.4M
$-41.4M
Gross Margin
ACAD
ACAD
BB
BB
Q1 26
Q4 25
90.8%
77.5%
Q3 25
92.2%
74.5%
Q2 25
92.2%
74.2%
Q1 25
91.7%
73.5%
Q4 24
91.6%
78.1%
Q3 24
92.5%
70.2%
Q2 24
92.5%
72.9%
Operating Margin
ACAD
ACAD
BB
BB
Q1 26
-1.7%
Q4 25
6.1%
8.4%
Q3 25
12.8%
8.9%
Q2 25
12.2%
1.6%
Q1 25
7.9%
-5.6%
Q4 24
59.1%
13.6%
Q3 24
12.6%
1.7%
Q2 24
12.6%
-10.5%
Net Margin
ACAD
ACAD
BB
BB
Q1 26
1.4%
Q4 25
96.3%
9.7%
Q3 25
25.8%
10.3%
Q2 25
10.1%
1.6%
Q1 25
7.8%
-5.2%
Q4 24
55.4%
-7.3%
Q3 24
13.1%
-15.6%
Q2 24
13.8%
-33.5%
EPS (diluted)
ACAD
ACAD
BB
BB
Q1 26
$0.02
Q4 25
$1.61
$0.02
Q3 25
$0.42
$0.02
Q2 25
$0.16
$0.00
Q1 25
$0.11
$-0.01
Q4 24
$0.86
$-0.02
Q3 24
$0.20
$-0.03
Q2 24
$0.20
$-0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACAD
ACAD
BB
BB
Cash + ST InvestmentsLiquidity on hand
$304.2M
Total DebtLower is stronger
$196.2M
Stockholders' EquityBook value
$741.1M
Total Assets
$1.6B
$1.2B
Debt / EquityLower = less leverage
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACAD
ACAD
BB
BB
Q1 26
Q4 25
$177.7M
$304.2M
Q3 25
$258.0M
$290.5M
Q2 25
$253.6M
$306.6M
Q1 25
$217.7M
$337.8M
Q4 24
$319.6M
$220.0M
Q3 24
$155.1M
$211.0M
Q2 24
$177.1M
$229.0M
Total Debt
ACAD
ACAD
BB
BB
Q1 26
Q4 25
$196.2M
Q3 25
$195.9M
Q2 25
$195.6M
Q1 25
$195.3M
Q4 24
Q3 24
Q2 24
Stockholders' Equity
ACAD
ACAD
BB
BB
Q1 26
Q4 25
$1.2B
$741.1M
Q3 25
$917.3M
$725.1M
Q2 25
$822.4M
$725.1M
Q1 25
$765.2M
$719.9M
Q4 24
$732.8M
$725.2M
Q3 24
$577.2M
$732.1M
Q2 24
$516.7M
$742.6M
Total Assets
ACAD
ACAD
BB
BB
Q1 26
$1.6B
Q4 25
$1.6B
$1.2B
Q3 25
$1.3B
$1.2B
Q2 25
$1.2B
$1.2B
Q1 25
$1.1B
$1.3B
Q4 24
$1.2B
$1.3B
Q3 24
$976.9M
$1.3B
Q2 24
$914.1M
$1.3B
Debt / Equity
ACAD
ACAD
BB
BB
Q1 26
Q4 25
0.26×
Q3 25
0.27×
Q2 25
0.27×
Q1 25
0.27×
Q4 24
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACAD
ACAD
BB
BB
Operating Cash FlowLast quarter
$18.3M
Free Cash FlowOCF − Capex
$17.4M
FCF MarginFCF / Revenue
12.3%
Capex IntensityCapex / Revenue
0.6%
Cash ConversionOCF / Net Profit
1.34×
TTM Free Cash FlowTrailing 4 quarters
$42.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACAD
ACAD
BB
BB
Q1 26
Q4 25
$-48.7M
$18.3M
Q3 25
$74.3M
$3.9M
Q2 25
$64.0M
$-18.0M
Q1 25
$20.3M
$41.6M
Q4 24
$40.4M
$6.0M
Q3 24
$63.2M
$-16.0M
Q2 24
$25.0M
$-15.1M
Free Cash Flow
ACAD
ACAD
BB
BB
Q1 26
Q4 25
$17.4M
Q3 25
$73.9M
$3.1M
Q2 25
$-18.9M
Q1 25
$41.2M
Q4 24
$5.2M
Q3 24
$63.2M
$-16.5M
Q2 24
$-16.5M
FCF Margin
ACAD
ACAD
BB
BB
Q1 26
Q4 25
12.3%
Q3 25
26.5%
2.4%
Q2 25
-15.5%
Q1 25
29.1%
Q4 24
3.6%
Q3 24
25.2%
-13.1%
Q2 24
-13.4%
Capex Intensity
ACAD
ACAD
BB
BB
Q1 26
Q4 25
0.6%
Q3 25
0.1%
0.6%
Q2 25
0.7%
Q1 25
0.3%
Q4 24
0.6%
Q3 24
0.0%
0.4%
Q2 24
1.1%
Cash Conversion
ACAD
ACAD
BB
BB
Q1 26
Q4 25
-0.18×
1.34×
Q3 25
1.03×
0.29×
Q2 25
2.40×
-9.47×
Q1 25
1.07×
Q4 24
0.28×
Q3 24
1.93×
Q2 24
0.75×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACAD
ACAD

Segment breakdown not available.

BB
BB

QNX$68.7M48%
Secure Communication$67.0M47%
Licensing$6.1M4%

Related Comparisons